Abstract
Bispecific monoclonal antibodies (bi-mAb), directed against a tumor-associated antigen and the CD3 or CD28 antigen on T lymphocytes, induce activation of resting T lymphocytes and target-specific tumor cell lysis. We now show that both necrosis and apoptosis contribute to T-cell-mediated tumor cell destruction. Even though T cells up-regulate FAS/APO-1 expression upon bi-mAb stimulation, FAS/APO-1-mediated apoptosis does not contribute to bi-mAb-mediated destruction of Hodgkin's cells. CD8+ lymphocytes were the most potent effectors of bi-mAb-mediated cytotoxicity and had the highest levels of mRNA coding for perforin and granzyme A and B. Ca2+-complexing agents, which abrogate perforin activity, led to decreased levels of necrosis, while inhibition of granzyme activity in effector or target cells had a similar effect on apoptosis. Granzyme-mediated apoptosis critically dependent on the proliferative state of the target cells, while perforin-induced necrosis was not cell-cycle-dependent. Our results underline the importance of the expression levels of perforin and granzymes in the effector T cells and of the proliferative state of the target cells in bi-mAb-mediated apoptosis and necrosis of tumor cells.
Citations
Oct 26, 1999·Experimental Gerontology·C SpauldingR B Effros
Apr 29, 1998·Immunology and Cell Biology·L F Lincz
Oct 21, 1998·Journal of Pediatric Gastroenterology and Nutrition·M ShinerD Branski
Aug 24, 2005·Genetic Vaccines and Therapy·Ali AziziFrancisco Diaz-Mitoma
Nov 5, 2011·BioDrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy·Lawrence G Lum, Archana Thakur
Sep 1, 2008·Expert Opinion on Drug Discovery·Lawrence G Lum, Zaid Al-Kadhimi
Jun 25, 2002·Expert Opinion on Biological Therapy·Bela Bodey
Jan 18, 2006·Experimental Hematology·Lawrence G LumRandall J Lee
Aug 28, 2012·Clinical Neurology and Neurosurgery·Makoto UchinoYukio Ando
Feb 11, 2004·Journal of Immunotherapy·Tina KornRoland E Kontermann
Sep 5, 2006·American Journal of Physiology. Heart and Circulatory Physiology·Kiyohiro OshimaLuyi Sen
Apr 29, 2016·Oncotarget·Juan MaMan Zhang
Oct 13, 2015·Current Opinion in Hematology·Divaya Bhutani, Lawrence G Lum
Apr 6, 2021·MAbs·Harbani K Malik-ChaudhryUdaya S Rangaswamy